Hypoglycemic Effect of Electroacupuncture at ST25 Through Neural Regulation of the Pancreatic Intrinsic Nervous System.

Molecular Neurobiology
Tiancheng XuB Xu

Abstract

Electroacupuncture (EA) is considered to have potential antidiabetic effects; however, the role of the pancreatic intrinsic nervous system (PINS) in EA-induced amelioration of type 2 diabetes (T2DM) remains unclear. Therefore, we investigated whether EA at ST25 exerts any beneficial effects on insulin resistance (IR), inflammation severity, and pancreatic β cell function via the PINS in a rat model of a high-fat diet-streptozotocin (HFD/STZ)-induced diabetes. To this end, Sprague Dawley rats were fed with HFD to induce IR, followed by STZ (35 mg/kg, i.p.) injection to establish the T2DM model. After hyperglycemia was confirmed as fasting glucose level > 16.7 mmol/L, the rats were treated with EA (2 mA, 2/15 Hz) for the next 28 days. Model rats showed increased serum glucose, insulin, IR, and TNF-α levels with a concomitant decrease in β cell function. Microscopy examination of the pancreas revealed pathological changes in islets, which reverted to near-normal levels after EA at ST25. EA improved islet cell morphology by increasing islet area and reducing vacuolation. EA at ST25 decreased transient receptor potential vanilloid 1 (TRPV1) and increased substance P (SP) and calcitonin gene-related peptide (CGRP) expression. Subsequ...Continue Reading

References

Jan 1, 1996·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·E ZoucasI Ihse
Jan 5, 2000·Journal of Ethnopharmacology·K L Joy, R Kuttan
Jun 28, 2005·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·K SrinivasanP Ramarao
Feb 8, 2006·Annual Review of Physiology·Sudha B Biddinger, C Ronald Kahn
Jul 11, 2006·The Journal of Clinical Investigation·Marc Prentki, Christopher J Nolan
Feb 3, 2007·The Journal of Clinical Investigation·Kevin J Tracey
Dec 7, 2007·Trends in Pharmacological Sciences·Anish Suri, Arpad Szallasi
Oct 6, 2009·Journal of the American Pharmacists Association : JAPhA·R Keith Campbell
Jul 2, 2010·Diabetes, Obesity & Metabolism·F Liang, D Koya
Sep 18, 2010·Trends in Endocrinology and Metabolism : TEM·Martin G MyersMichael W Schwartz
Jan 5, 2011·Cell Metabolism·Rebecca G BakerSankar Ghosh
Mar 6, 2012·Cell·Varman T Samuel, Gerald I Shulman
Aug 2, 2013·Diabetes Care·Ralph A DeFronzoMuhammad Abdul-Ghani
Sep 5, 2013·Journal of General Internal Medicine·Michael S Radin
May 23, 2014·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Jieyun YinJiande D Z Chen
Aug 26, 2014·Nature Communications·Melissa F BreretonFrances M Ashcroft
May 17, 2015·Acupuncture in Medicine : Journal of the British Medical Acupuncture Society·Qi-Ming XueNing Li
Jan 30, 2016·Diabetes·Alice MarmugiIsabelle Leclerc
Jul 29, 2017·Acupuncture in Medicine : Journal of the British Medical Acupuncture Society·Huan-Huan TianYue-Ying Wang
Sep 28, 2017·Molecular Metabolism·Anna M D'souzaTimothy J Kieffer
Nov 11, 2017·Scientific Reports·Do-Hee KimHee Young Kim
Nov 16, 2017·Trends in Molecular Medicine·Dorte X GramArpad Szallasi
Apr 9, 2018·Molecular and Cellular Endocrinology·L ShcherbinaN Wierup
Nov 27, 2018·Molecular Metabolism·Joey Bou KaramAbdelfattah El Ouaamari
Mar 8, 2019·Frontiers in Neuroscience·Wenjing LiLei Sha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.